J3244 Injection. tigecycline (accord)
Also known as: tigecycline, tigecycline Accord, broad-spectrum antibiotic
Tigecycline (Accord) injection is a broad-spectrum tetracycline antibiotic formulation by Accord Pharmaceuticals with same clinical indication as other tigecycline preparations.
In Plain Language
strong infection medication; resistant bacteria treatment
Clinical Context
Indicated for complicated skin/soft tissue infections, complicated intra-abdominal infections, and community-acquired pneumonia caused by resistant organisms. Same indications and administration as other tigecycline products.
RVU Information
CPT J3244 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3244?
CPT J3244 (Injection. tigecycline (accord)) is a J Codes (Drugs) code. Tigecycline (Accord) injection is a broad-spectrum tetracycline antibiotic formulation by Accord Pharmaceuticals with same clinical indication as other tigecycline preparations.
How is J3244 administered?
CPT J3244 is administered by a healthcare provider, typically via injection or infusion. Indicated for complicated skin/soft tissue infections, complicated intra-abdominal infections, and community-acquired pneumonia caused by resistant organisms. Same indications and administration as other tigecycline products. It is used by Infectious Disease, Critical Care, Internal Medicine.
When is CPT J3244 used?
Indicated for complicated skin/soft tissue infections, complicated intra-abdominal infections, and community-acquired pneumonia caused by resistant organisms. Same indications and administration as other tigecycline products.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.